Month: September 2019

Question: What goes up and hasn’t come down? Answer: The use of Active Surveillance in the U.S. A February, 2019 study[i] examined U.S. management trends for low-risk prostate cancer since 2010. Prior to that, the standard of care for low-to-intermediate risk PCa was an “elephant gun” approach aimed at eradicating PCa by obliterating the gland. keep reading

Many of us recall our high school history courses as painful memorizing of timelines: empires rising and falling, wars, plagues, names of kings and queens, etc. No doubt the thought crossed our minds at least once: why do I need to know this stuff? Then along came the History Channel, with vivid documentaries filled with keep reading